BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 8, 2002
View Archived Issues
Chiron Buying Matrix For $61M, Adding Tezacitabine To Pipeline
Chiron Corp., its eyes firmly focused on the cancer therapeutic tezacitabine, is acquiring Matrix Pharmaceutical Inc. for $61 million in cash.
Read More
Alexion Starts Phase III Study With Heart Drug Pexelizumab
Read More
Rodents Modeling Parkinson s Disease Generate Dopaminergic Neurons To Stem Losses In PD
Read More
Tripos Collaborates With Pfizer To Help Build Compound Library
Read More
Other News To Note
Read More
Structural GenomiX Partners With Millennium, Aventis For Discovery
Read More
Alteon Raising $18.6M To Fund Discovery, Development Work
Read More
Genencor, Seattle Genetics Align To Develop Cancer Therapeutics
Read More
Appointments And Advancements
Read More